Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1.
about
Use and abuse of dendritic cells by Toxoplasma gondiiSTAT1 Signaling in Astrocytes Is Essential for Control of Infection in the Central Nervous System.Inflammation and the two-hit hypothesis of schizophrenia.Neonatal infection with neurotropic influenza A virus induces the kynurenine pathway in early life and disrupts sensorimotor gating in adult Tap1-/- mice.Expulsion of Trichuris muris is associated with increased expression of angiogenin 4 in the gut and increased acidity of mucins within the goblet cell.Comparative transcriptome analysis of equine alveolar macrophagesIndoleamine 2,3-dioxygenase 1 is a lung-specific innate immune defense mechanism that inhibits growth of Francisella tularensis tryptophan auxotrophsIdentification of novel genes in intestinal tissue that are regulated after infection with an intestinal nematode parasiteThe Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists.A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase.Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunityThe neurotropic parasite Toxoplasma gondii increases dopamine metabolism.Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection.The Group 3 Innate Lymphoid Cell Defect in Aryl Hydrocarbon Receptor Deficient Mice Is Associated with T Cell Hyperactivation during Intestinal Infection.Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation.Apicomplexan parasite, Eimeria falciformis, co-opts host tryptophan catabolism for life cycle progression in mouseKynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2(+/-) mice, using liquid chromatography-tandem mass spectrometry.Metabolomic Profiling of Mice Serum during Toxoplasmosis Progression Using Liquid Chromatography-Mass Spectrometry.Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenaseCCR2 receptor is essential to activate microbicidal mechanisms to control Toxoplasma gondii infection in the central nervous system.Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration.Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid fever.The importance of NAD in multiple sclerosisToxoplasma gondii TgIST co-opts host chromatin repressors dampening STAT1-dependent gene regulation and IFN-γ-mediated host defenses.Direct Effect of Two Naphthalene-Sulfonyl-Indole Compounds on Toxoplasma gondii TachyzoiteHeme oxygenase-1 activity is involved in the control of Toxoplasma gondii infection in the lung of BALB/c and C57BL/6 and in the small intestine of C57BL/6 mice.Toxoplasma gondii Inhibits gamma interferon (IFN-γ)- and IFN-β-induced host cell STAT1 transcriptional activity by increasing the association of STAT1 with DNA.Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly.Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia.Tryptophan metabolism, from nutrition to potential therapeutic applications.Immunoprotective role of indoleamine 2,3-dioxygenase in engraftment of allogenic skin substitute in wound healing.Persistent infectious diseases say - IDO. Role of indoleamine-2,3-dioxygenase in disease pathogenesis and implications for therapy.Feast or famine: the host-pathogen battle over amino acids.Possible link between Toxoplasma gondii and the anosmia associated with neurodegenerative diseases.Central Nervous System Infection with Borna Disease Virus Causes Kynurenine Pathway Dysregulation and Neurotoxic Quinolinic Acid ProductionToxoplasma Effectors Targeting Host Signaling and Transcription.Dendritic cells and parasites: from recognition and activation to immune response instruction.Nicotinic acid-mediated activation of both membrane and nuclear receptors towards therapeutic glucocorticoid mimetics for treating multiple sclerosis.Mycobacterium tuberculosis in the Face of Host-Imposed Nutrient Limitation.The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects.
P2860
Q26852870-E9A1071E-CCAA-4AAA-ABC5-C3B0815D6C39Q30275440-96F2727A-F613-4519-B66B-625035B26196Q30422062-89E572E3-FAA5-47F3-87A9-93A3D26FAA8FQ30475641-B306DFE7-A1D2-47F4-B3C0-D5EE1F2D9754Q33512135-488B968C-6C1C-490F-8950-9BDE6B45BE23Q33625585-74B7CF42-91E6-49B7-B715-EB5545C2E5A8Q33877246-D7045CD8-75DA-42D8-A262-4617C2792527Q34428271-41BB7789-E9FB-4474-AEB1-65BB07869924Q34553267-03109FE1-C86B-49CA-9C99-BF2ED9A57134Q34631232-F7B8469C-95EB-4333-9257-1623AFAB1A84Q35088408-7015A57B-3FBF-4556-830F-CBFF9694C2A0Q35225745-4E4A5166-FCED-4BC8-9CB4-DD2FD3AC21DBQ35623712-6F44162D-1669-4F64-B8DA-9727CBE3B062Q35641191-F1BA42CF-7975-4F6E-A09A-50F3B15C5B0CQ35847753-B8CC8506-98D1-4E18-9E5E-55C2A722DF34Q36016868-35F4EB1C-7898-4FDE-B2BD-356BD08D2FB5Q36131465-80088607-B057-4870-AD3F-DFBDDEA3E7DDQ36500514-8F3074EC-F935-48AD-AD01-3786B49D6152Q36632492-322DDABF-0FB5-48A9-9B14-2A0126B34ACEQ36855774-E181B61A-003B-433A-9B9E-AD396AF4662FQ36945216-46733BAE-F211-4333-99EE-A3BC3F0088A6Q36949893-7C9E1393-14AA-401C-B1B4-EA8A8952E9A3Q37118012-729892BE-BC6D-48A7-A00F-EE4D1A316A50Q37197979-2831A376-9ED8-41A0-B789-CC2AF5AF0180Q37283682-278A7806-F8FF-48CF-AAAF-9C61106AD41EQ37364789-E604B088-A47A-4962-ABEA-01B9BC1C33E1Q37546374-E514F135-AA16-4EF7-BD02-A39CF37794FDQ37577380-A2DD83DB-B40C-4138-A4EC-A9069000C3D3Q37580309-CD961B8C-AB55-49C8-A81E-05526C84C101Q37792850-DE8FA2CA-6BAF-4316-9BAB-3852F413B065Q37976231-DA56BB33-7865-4E4A-877C-0EBC739D08A8Q38061723-FA221677-ECD4-4D3A-AA18-13DB309E757EQ38092233-AE9FD6E7-A5E3-4A71-AB63-EE922C34F064Q38177635-839A30DE-9543-42B7-B5A0-D57E145E0FF0Q38705909-960B0E7D-84E9-452E-8BDF-7CC0A24CC437Q38731005-34DDF5B3-71DD-4DB0-BD59-40EA1EB3A575Q38944438-5CB910EE-F294-409E-9BE8-650C0A0F137CQ39303280-644C3DAF-E28C-41AE-B710-927368578B60Q39361724-6C78DB64-18C4-4263-90CF-E6DC76B4A378Q39825479-1570485A-AB59-4117-A72F-894ADCA19B65
P2860
Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Expression of indoleamine 2,3- ...... nterferon regulatory factor 1.
@en
Expression of indoleamine 2,3- ...... nterferon regulatory factor 1.
@nl
type
label
Expression of indoleamine 2,3- ...... nterferon regulatory factor 1.
@en
Expression of indoleamine 2,3- ...... nterferon regulatory factor 1.
@nl
prefLabel
Expression of indoleamine 2,3- ...... nterferon regulatory factor 1.
@en
Expression of indoleamine 2,3- ...... nterferon regulatory factor 1.
@nl
P2093
P2860
P1476
Expression of indoleamine 2,3- ...... nterferon regulatory factor 1.
@en
P2093
Cibele V Rodrigues
Jacqueline I Alvarez-Leite
Luiz F L Reis
Marcelo M Santoro
Neide M Silva
Ricardo T Gazzinelli
P2860
P304
P356
10.1128/IAI.70.2.859-868.2002
P407
P577
2002-02-01T00:00:00Z